Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 283(45): 30699-706, 2008 Nov 07.
Article in English | MEDLINE | ID: mdl-18755686

ABSTRACT

Previous studies showed that valyl-tRNA synthetase of Saccharomyces cerevisiae contains an N-terminal polypeptide extension of 97 residues, which is absent from its bacterial relatives, but is conserved in its mammalian homologues. We showed herein that this appended domain and its human counterpart are both nonspecific tRNA-binding domains (K(d) approximately 0.5 microm). Deletion of the appended domain from the yeast enzyme severely impaired its tRNA binding, aminoacylation, and complementation activities. This N-domain-deleted yeast valyl-tRNA synthetase mutant could be rescued by fusion of the equivalent domain from its human homologue. Moreover, fusion of the N-domain of the yeast enzyme or its human counterpart to Escherichia coli glutaminyl-tRNA synthetase enabled the otherwise "inactive" prokaryotic enzyme to function as a yeast enzyme in vivo. Different from the native yeast enzyme, which showed different affinities toward mixed tRNA populations, the fusion enzyme exhibited similar binding affinities for all yeast tRNAs. These results not only underscore the significance of nonspecific tRNA binding in aminoacylation, but also provide insights into the mechanism of the formation of aminoacyl-tRNAs.


Subject(s)
RNA, Transfer/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Transfer RNA Aminoacylation/physiology , Valine-tRNA Ligase/metabolism , Amino Acyl-tRNA Synthetases/genetics , Amino Acyl-tRNA Synthetases/metabolism , Escherichia coli/enzymology , Escherichia coli/genetics , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Humans , Protein Binding/physiology , Protein Structure, Tertiary/physiology , RNA, Transfer/genetics , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics , Sequence Homology, Amino Acid , Valine-tRNA Ligase/genetics
2.
Bioresour Technol ; 99(14): 6046-53, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18262784

ABSTRACT

Pretreatment with dilute sulfuric acid of silvergrass was compared with the pretreatment's effect on other commonly used lignocellulosic materials, namely rice straw and bagasse, in order to evaluate the potential of this feedstock for ethanol production. The highest yield of xylose from silvergrass was between 70% and 75%, which was similar to bagasse. However, silvergrass gave a higher level of fermentability than bagasse using the hydrolysate because less acetic acid was formed. The release of sugars resulted in an about 2.0-fold increase in specific surface area of the pretreated silvergrass. Increasing the specific surface area did not obviously enhance enzymatic digestibility. The hydrophilicity of the acid pretreated silvergrass was characterized using its Fourier transform infrared (FTIR) spectra. The increase in hydrophilicity may enhance enzymatic adsorption onto lignin and increase the accumulation of cellobiose for enzymatic hydrolysis as pretreatment severity increases.


Subject(s)
Acids/pharmacology , Ethanol/metabolism , Poaceae/metabolism , Fermentation , Hydrolysis , Kinetics , Spectroscopy, Fourier Transform Infrared , Taiwan
3.
Am J Respir Cell Mol Biol ; 38(5): 559-65, 2008 May.
Article in English | MEDLINE | ID: mdl-18096875

ABSTRACT

Our previous study had shown that advanced stages of lung adenocarcinomas (ADC) was frequently associated with overexpression of hepatocyte growth factor (HGF), which has multipotent and anti-apoptotic activities. In this study, we examined the effect of HGF on gene expression of apoptosis-inducing factor (AIF) and cisplatin sensitivity in lung ADC cells. Expression of AIF was determined by immunocytochemistry and confocal immunofluorescence microscopy. Our data show that addition of HGF suppressed AIF expression and increased cisplatin resistance. The effect could be through HGF receptor and its downstream effector, focal adhesion kinase (FAK). Interestingly, knockout of FAK gene increased AIF expression and drug sensitivity. Re-introduction of FAK gene, on the other hand, restored drug resistance. These results suggested that HGF might induce cisplatin resistance via c-Met to activate FAK and down-regulate AIF expression.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis Inducing Factor/genetics , Cisplatin/pharmacology , Down-Regulation/physiology , Drug Resistance, Neoplasm/physiology , Hepatocyte Growth Factor/physiology , Lung Neoplasms/drug therapy , Animals , Apoptosis Inducing Factor/antagonists & inhibitors , Apoptosis Inducing Factor/biosynthesis , Cell Line, Tumor , Cells, Cultured , Embryo, Mammalian , Fibroblasts/metabolism , Focal Adhesion Kinase 1/metabolism , Hepatocyte Growth Factor/genetics , Humans , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Mice , Proto-Oncogene Proteins c-met/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...